Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China

BACKGROUND AND AIMS: Metabolic dysfunction-associated fatty liver disease (MAFLD) was proposed to substitute NAFLD in 2020. This new term highlights the systematic metabolic disturbances that accompany fatty liver. We evaluated the correlations between MAFLD and subclinical carotid atherosclerosis (...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Fang, Wang, Xiao-Ming, Wang, Changquan, Huang, Xuewei, Liu, Ye-Mao, Qin, Juan-Juan, Zhang, Peng, Ji, Yan-Xiao, She, Zhi-Gang, Cai, Jingjing, Li, Huo-ping, Zhang, Xiao-Jing, Li, Hongliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110917/
https://www.ncbi.nlm.nih.gov/pubmed/37082131
http://dx.doi.org/10.3389/fendo.2023.1109673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110917/
https://www.ncbi.nlm.nih.gov/pubmed/37082131
http://dx.doi.org/10.3389/fendo.2023.1109673

Ejemplares similares